Topics:

GAVI Alliance aims to immunize 30 million girls against HPV

Tools

The GAVI Alliance wants to immunize 30 million girls worldwide with HPV vaccines by 2020. Pilot projects in select countries--mainly in sub-Saharan Africa--will roll out next year. GAVI is working with Merck ($MRK) and GlaxoSmithKline ($GSK) to nail down the most affordable prices for HPV vaccines. In 2011, Merck said it would provide the vaccine at $5 per dose, a 64% reduction in the current lowest public price. The FDA licenses two HPV vaccines in the United States: Merck's Gardasil and GSK's Cervarix. Jabs will go to girls ages 9 to 13. Release